Coronavirus SARS-CoV-2 testing
Without doctors referral, the SARS-CoV-2019 PCR test costs 37 EUR.
It is mandatory to include which type of test will be needed (AG or PCR) and the diagnosis of the patient in the testing request.
To request state financed testing for COVID-19 for your patients, fill THIS FORM.
To access the form you will be requested to electronically authenticate through one of the available authentication services.
We recommend that the Covid-19 test be performed in conjunction with an influenza express test and/or a respiratory infection panel to identify the disease pathogen. The laboratory will first perform the SARS-CoV-2019 test.
|Test name||Laboratory code||Price EUR|
|Flu express test||6378||12,70|
|Respiratory infection panel (viruses)||5910||47,30|
|Respiratory infection panel (viruses and bacteria)||5915||122,30|
Information about the use of saliva samples for SARS-CoV-2 RNA detection
We have prepared a short explanation about in which cases saliva samples can be used for the detection of SARS-CoV-2 presence.
It has been demonstrated by various international and E. Gulbja Laboratorija studies, as well as described in the guidelines of the European Centre for Disease Prevention and Control, that saliva samples can be used to detect the presence of SARS-CoV-2 virus RNA in humans.
One of the main advantages of a saliva sample is the ease of obtaining the material, which can be performed by the patient him- or herself, and which does not cause discomfort during the sample collection process. Because of the fact that the collection of the sample does not require specially trained medical personnel, this can significantly expand the range of patients that can be tested.
Detection of the virus in a saliva sample is intended for screening purposes, i.e., to find infected and/or infectious individuals in a group, and is to be performed on a regular basis, for example in a work group environment, in an educational establishment or in an outbreak area.
It should be noted that saliva samples cannot be used in all cases (both clinical and epidemiological).
Saliva samples should be used in the acute phase of the SARS-CoV-2 viral infection until approximately day 8 after the onset of clinical symptoms, and should NOT be used for the purposes of quarantine termination or other control testing in the following cases:
- The patient has previously had a positive SARS-CoV-2 viral RNA result from an oropharyngeal/nasopharyngeal swab specimen
- The patient has previously had a positive SARS-CoV-2 viral RNA result in a saliva sample
- The patient’s blood sample contains specific antibodies to the SARS-CoV-2 virus
E. Gulbja Laboratorija does not test samples like this.
Additional information on Covid-19 (link) Other news